USP22 and malignant colon neoplasm: In fact, immunoblotting analysis confirmed dramatically higher protein expression levels of both CCNB1 and USP22 in colon cancer tissues (in 7 of 10 patients) compared with those in adjacent normal controls (Figure 1c).